Birmingham, West Midlands -- (SBWIRE) -- 01/23/2014 -- Value Penny Stocks issues special report on Keryx Biopharmaceuticals (NASDAQ:KERX), Applied Materials, Inc. (NASDAQ:AMAT), DryShips Inc. (NASDAQ:DRYS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).
Keryx Biopharmaceuticals (NASDAQ:KERX) ended its recent business day with the loss of -5.07% and closed at the price of $14.60 after opening at $14.51. The stock traded during its last trading session with the total volume of 5.83 million shares, as compared to its average volume of 82.32 million shares. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States.
Has KERX Found The Bottom and Ready To Move Up? Find Out Here
Applied Materials, Inc. (NASDAQ:AMAT) remained among the day advancers and traded with volume of 5.77 million shares in the last session, as compared to average volume of 9.17 million shares. In comparison with 52 week range of $12.54 - $18.18, it faced lowest price of $17.56 during the last trading session whereas its day highest price was $17.72. The company’s total market capitalization is $21.27 billion, along with 1.20 billion shares outstanding. Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, flat panel display, solar photovoltaic (PV), and related industries worldwide. The company’s Silicon Systems Group segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits.
Why Should Investors Buy AMAT After The Recent Gain? Just Go Here and Find Out
DryShips Inc. (NASDAQ:DRYS) showed 5.66 million shares in volume during the last trading session, while the average trading volume remained 17.78 million shares. The stock kicked off its trading session at $3.81 and closed at $3.81. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units.
Is DRYS Buy After The Recent Price Movement? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock traded during its last trading session with the total traded volume of 5.21 million shares versus its average volume of 5.37 million shares. The company opened its trade at the price of $7.31 and its closing price was $7.49 after gaining 2.32% for the day. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)